OncoCyte
OCX
$2.48
Share price
1.64%
Change (1 day)
818.52%
Change (1 year)
Categories
OncoCyte (OCX) - Cash on Hand
Cash on Hand as of September 2023 : $14.22 M
According to OncoCyte
's latest financial reports the company has $14.22 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
OncoCyte - Cash on Hand chart (from 2014 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $20.42 M | -39.66% |
| 2021-12-31 | $33.85 M | 333% |
| 2020-12-31 | $7.81 M | -65.18% |
| 2019-12-31 | $22.45 M | 165.32% |
| 2018-12-31 | $8.46 M | 1.22% |
| 2017-12-31 | $8.36 M | -32.64% |
| 2016-12-31 | $12.41 M | 17.78% |
| 2015-12-31 | $10.53 M | 197.91% |
| 2014-12-31 | $3.53 M | -25.24% |
| 2013-12-31 | $4.73 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.20 B | 1,363.63% | 🇺🇸 USA |